Founded in 2010, Avraham said it had now raised $14.7m to test patients with Alzheimer's disease after a $9m round in April 2010.
Avraham Pharmaceuticals, an Israel-based drugs developer, has raised $5.7m from a consortium including Tel Aviv-listed Clal Biotechnology and university venturing funds.
Founded in 2010, Avraham said it had now raised $14.7m to to test patients with Alzheimer’s disease after a $9m round in April 2010.
The other investors in the round were Yissum Technology Transfer Company of the Hebrew University of Jerusalem, Technion Research and Development Foundation and the Pontifax fund.
Yissum and Integra Holdings, Yissum’s biotech holdings company, now…
